Articles Authored by Kelsy Ketchum
Findings from two clinical studies were reported at Digestive Disease Week earlier this month that supported use of the firm's EsoCheck device and EsoGuard test.
Convergent Genomics Building Data on Urine-Based Assay to Diagnose, Monitor Urothelial Carcinoma
The Oregon Health and Science University spinout also recently presented data suggesting the test could help predict future urothelial carcinoma.
The firm's platform combines single-cell microbiology and machine learning to deliver a result in four to six hours.
QuidelOrtho Q1 Revenues Drop 16 Percent
The firm's non-respiratory revenue was up 5 percent due to the Labs business, while respiratory revenue was down 72 percent.
Bio-Techne Fiscal Q3 Revenues Tick Up 1 Percent as Firm Faces Macroeconomic Headwinds
Diagnostics and Genomics segment revenues ticked down 3 percent year over year, while Protein Sciences revenues were up 3 percent.
Roche Touts New, Upcoming Launches as Dx Revenues Drop 31 Percent
The company's point-of-care revenues dropped 73 percent, while molecular lab sales declined 50 percent.
The firm saw total revenues decrease 7 percent, with core revenues down 4 percent and base business core revenue growth of 6 percent.
The firm's Lodestar Dx platform uses loop-mediated isothermal amplification to detect pathogens causing urinary tract infections.
The firm's planned launches include a respiratory virus panel, a gastrointestinal panel, and a fingerstick tuberculosis test, it revelaed this week at ECCMID.
Multicenter Study Finds BioFire Joint Infection Panel Shows High Accuracy Despite Limitations
The assay received de novo authorization from the US Food and Drug Administration and CE-IVD marking last year.